3 takeaways on PE in 2021 (Becker’s GI & Endoscopy)
Despite COVID-19-related disruptions, a return to pre-pandemic patient volumes in many specialties reinforced investor confidence and increased expectations for market activity in 2021.
For sale — Audax expects to sell Gastro Health in 2021 (Becker’s GI & Endoscopy)
In what’s shaping up to be a banner year of private equity investment in gastroenterology, it is reported that Audax Private Equity will sell Miami-based Gastro Health in 2021.
CRH Medical could be acquired for $369M+ (Becker’s GI & Endoscopy)
Well Health reached an arrangement agreement to acquire all issued and outstanding shares of CRH Medical at $4 per share.
Study Aims to Settle Bidirectional Endo Debate (Gastroenterology & Endoscopy News)
Gastroscopy should precede colonoscopy using carbon dioxide insufflation in same-day bidirectional endoscopies, according to a team of Canadian researchers.
Defining Wellness in IBD (Medscape)
Physicians treating patients with IBD typically focus on disease and symptom management along with quality of life measures, but the latter are not the final word on patient well-being.
Video: How Do Gut Bacteria Affect COVID-19 Severity? (Medscape)
COVID-19 patients have been found to have poorer gut microbiome compositions compared with those without the disease.
6 recent updates on colonoscopy (Becker’s GI & Endoscopy)
Gastroenterology’s mainstay procedure has seen a flurry of recent developments, and the largest was the closure of the colonoscopy loophole.